Cargando…
Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment
BACKGROUND: Rectum cancer is a type of colorectal cancer. Its etiology and etiopathogenesis are similar to other colon diseases. We aimed to evaluate the tumor budding for predicting prognosis of resected rectum cancer patients. METHODS: We retrospectively collected the data of 75 operated rectum ad...
Autores principales: | Demir, Atakan, Alan, Ozkan, Oruc, Ertugrul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419499/ https://www.ncbi.nlm.nih.gov/pubmed/30871581 http://dx.doi.org/10.1186/s12957-019-1588-6 |
Ejemplares similares
-
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis
por: Farid, Mohamad, et al.
Publicado: (2020) -
A two-team approach for the complete resection of a bulky gastrointestinal stromal tumor on the anterior wall of the lower rectum after neoadjuvant treatment
por: Murakami, Koichi, et al.
Publicado: (2022) -
High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection
por: Ito, Takahiro, et al.
Publicado: (2020) -
Treatment of anastomotic leakage after rectal cancer resection: The TENTACLE–Rectum study
por: van Workum, Frans, et al.
Publicado: (2020) -
Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
por: Trotsyuk, Iryna, et al.
Publicado: (2019)